Hospital Sultanah Aminah, Johor Bahru, Malaysia; Monash University Malaysia, Malaysia.
Hospital Sultanah Aminah, Johor Bahru, Malaysia.
Cancer Epidemiol. 2022 Oct;80:102211. doi: 10.1016/j.canep.2022.102211. Epub 2022 Jul 11.
Esophageal cancer is the sixth leading cause of cancer death worldwide with considerable geographical histological variation There is a paucity of data in esophageal cancer in demographics, histology, and survival among the multi-ethnic Malaysian population. This paper is a review of esophageal cancer epidemiology and survival among esophageal cancer patients from data collected by the Malaysian Upper Gastrointestinal Surgical Society.
This is a multicenter retrospective observational study of esophageal cancer patients from six upper gastrointestinal surgical centers in Malaysia between 2005 and 2019. Patient characteristics, histological type and stage were compared and survival analyzed.
There were 820 patients with esophageal cancer included, where 442 (53.9 %) cases had squamous cell carcinoma (SCC) and 378 (46.1 %) had adenocarcinomas (AC). Malays were the predominant ethnicity with AC (66.7 %) while Indians were the ethnic majority (74.6 %) with SCC. Majority of patients (56.8 %) presented as stage IV disease. Overall, the 1-, 3-, and 5-years' survival were 35.8 %, 13.8 % and 11.0 %, respectively. Surgical resection with curative intent yielded the best 5-year survival (29.4 %). Intervention in stage IV AC yielded superior survival when compared to SCC (median survival, 7.9 months vs 4.8 months; p, 0.018) Our series demonstrated an increase in AC to SCC over the last 15 years.
There was an ethnic preponderance seen between different histology in this region, not previously discussed. An increase in AC was observed over the last 15 years. Late diagnosis seen in most patients imparts poor prognosis as curative surgery affords the best outcome.
食管癌是全球第六大癌症死亡原因,具有显著的地理组织学差异。在多民族的马来西亚人群中,食管癌在人口统计学、组织学和生存率方面的数据很少。本文回顾了马来西亚上消化道外科学会收集的数据中,食管癌患者的流行病学和生存率。
这是一项对 2005 年至 2019 年间来自马来西亚六家上消化道外科中心的食管癌患者进行的多中心回顾性观察性研究。比较了患者的特征、组织学类型和分期,并分析了生存率。
共纳入 820 例食管癌患者,其中 442 例(53.9%)为鳞状细胞癌(SCC),378 例(46.1%)为腺癌(AC)。马来人是主要的族群,其中 AC 占主导地位(66.7%),而印度人是 SCC 的主要族群(74.6%)。大多数患者(56.8%)表现为 IV 期疾病。总的来说,1 年、3 年和 5 年的生存率分别为 35.8%、13.8%和 11.0%。以治愈为目的的手术切除获得了最好的 5 年生存率(29.4%)。与 SCC 相比,IV 期 AC 的干预措施获得了更好的生存(中位生存时间,7.9 个月比 4.8 个月;p,0.018)。我们的研究表明,在过去的 15 年中,AC 与 SCC 的比例有所增加。
在该地区,不同组织学之间存在种族优势,这一点以前没有讨论过。在过去的 15 年中,AC 的发病率有所增加。大多数患者的晚期诊断导致预后不良,因为根治性手术可获得最佳效果。